Skip to main content

Table 2 Clinical outcomes stratified according to T2DM and coronary collateralization

From: Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion

VariableAll patients (n = 533)Non-diabetes (n = 335) (63%)Diabetes (n = 198) (37%)p value (non-diabetes vs diabetes)
AllGood CC (n = 237) (71%)Poor CC (n = 98) (29%)p valueAllGood CC (n = 118) (60%)Poor CC (n = 80) (40%)p value
MACCEs (composite)144 (27%)68 (19.4%)41 (17.3%)27 (27.6%)0.03476 (38%)41 (35%)35 (44%)0.201< 0.001
All cause death8 (1.5%)5 (1.5%)3 (1.3%)2 (2.0%)0.5953 (1.5%)03 (3.8%)0.0340.983
Cardiac death5 (0.9%)3 (0.9%)1 (0.4%)2 (2.0%)0.1522 (1.0%)02 (2.5%)0.0840.895
Non-fatal MI0000NS000NSNS
Non-fatal stroke17 (3.2%)8 (2.4%)7 (2.9%)1 (1.0%)0.2929 (4.5%)6 (5.1%)3 (3.8%)0.6580.171
Repeat revascularization125 (23.5%)61 (18.2%)36 (15.2%)25 (25.5%)0.02664 (32%)35 (30%)29 (36%)0.331< 0.001
ISR of CTO lesion65 (12.2%)29 (8.7%)15 (6.3%)14 (14.3%)0.01836(18%)20 (17%)16 (20%)0.5850.001
New lesion or lesion progression67 (12.6%)33 (9.9%)22 (9.3%)11 (11.2%)0.58734 (17%)16 (14%)18 (23%)0.1020.014
  1. T2DM type 2 diabetes mellitus, CC coronary collateralization, MACCEs major adverse cardio-cerebral events, MI myocardial infarction, ISR in-stent restenosis, CTO chronic total occlusion